ORIGINAL ARTICLE Open questions about metabolically normal obesity
暂无分享,去创建一个
[1] V. Messier,et al. Identifying Metabolically Healthy but Obese Individuals in Sedentary Postmenopausal Women , 2010, Obesity.
[2] L. Lynch,et al. The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity , 2010, PloS one.
[3] L. McLaren,et al. Social class, gender, and time use: implications for the social determinants of body weight? , 2009, Health reports.
[4] S. Nikkari,et al. Lipids in Health and Disease , 2009 .
[5] J. Kuk,et al. Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality? , 2009, Diabetes Care.
[6] E. Demerath,et al. Genetic analysis of self-reported physical activity and adiposity: The Southwest Ohio Family Study , 2009, Public Health Nutrition.
[7] A. Tchernof,et al. Fat Depot‐specific Impact of Visceral Obesity on Adipocyte Adiponectin Release in Women , 2009, Obesity.
[8] M. Roden,et al. Ectopic lipids and organ function , 2009, Current opinion in lipidology.
[9] C. Aguilar-Salinas,et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.
[10] W. Hul,et al. Association of SIRT1 gene variation with visceral obesity , 2008, Human Genetics.
[11] K. Reynolds,et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.
[12] Fritz Schick,et al. Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.
[13] G. Siest,et al. Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study , 2008, International Journal of Obesity.
[14] E. Lambert,et al. Determinants of Insulin‐resistant Phenotypes in Normal‐weight and Obese Black African Women , 2008, Obesity.
[15] R. Rabasa-Lhoret,et al. Metabolically healthy but obese women: effect of an energy-restricted diet , 2008, Diabetologia.
[16] Kieran Clarke,et al. Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[17] R. Vasan,et al. Bmc Medical Genetics Genome-wide Association to Body Mass Index and Waist Circumference: the Framingham Heart Study 100k Project , 2022 .
[18] Sabine Brasche,et al. Weight change, weight cycling and mortality in the ERFORT Male Cohort Study , 2007, European Journal of Epidemiology.
[19] Tracey McLaughlin,et al. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. , 2007, Archives of internal medicine.
[20] J. Meigs,et al. Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population , 2007, Diabetes Care.
[21] C. Tsigos,et al. Stress, Visceral Obesity, and Metabolic Complications , 2006, Annals of the New York Academy of Sciences.
[22] Ralph B D'Agostino,et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.
[23] Y. Jang,et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women , 2006, International Journal of Obesity.
[24] D. Prud'homme,et al. Psychosocial profile of the metabolically healthy but obese postmenopausal woman. , 2006, Diabetes & metabolism.
[25] G. Reaven. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals , 2005, Diabetes & vascular disease research.
[26] Remi Rabasa-Lhoret,et al. The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.
[27] C. Gallou-Kabani,et al. Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. , 2005, Diabetes.
[28] F. Leonetti,et al. Prevalence of uncomplicated obesity in an Italian obese population. , 2005, Obesity research.
[29] H. Lamb,et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.
[30] A. Karelis,et al. Can we identify metabolically healthy but obese individuals (MHO)? , 2004, Diabetes & metabolism.
[31] R. Ross,et al. Duration of overweight and metabolic health risk in American men and women. , 2004, Annals of epidemiology.
[32] C. Lamendola,et al. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. , 2004, Metabolism: clinical and experimental.
[33] H. Oflaz,et al. Determination of endothelial function and early atherosclerotic changes in healthy obese women. , 2003, Diabetes, nutrition & metabolism.
[34] T. Garland,et al. Genetic selection of mice for high voluntary wheel running: effect on skeletal muscle glucose uptake. , 2001, Journal of applied physiology.
[35] E. A. Sims,et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? , 2001, The Journal of clinical endocrinology and metabolism.
[36] R. Hanson,et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. , 2000, Diabetes.
[37] S. Reis,et al. Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group. , 2000, Journal of the American College of Cardiology.
[38] D A Follmann,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .
[39] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.
[40] M. Thun,et al. Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.
[41] M. Matsuda,et al. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.
[42] J. Levine,et al. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. , 1999, Science.
[43] S. Kiechl,et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. , 1998, Diabetes.
[44] E. Ferrannini,et al. Influence of duration of obesity on the insulin resistance of obese non-diabetic patients , 1998, International Journal of Obesity.
[45] E. Ferrannini,et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.
[46] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[47] Manning Feinleib,et al. Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.
[48] G. Shulman,et al. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. , 1997, Diabetes.